Literature DB >> 12581866

PKC epsilon -mediated ERK1/2 activation involved in radiation-induced cell death in NIH3T3 cells.

Yoon-Jin Lee1, Jae-Won Soh, Doo-Il Jeoung, Chul-Koo Cho, Gil Ja Jhon, Su-Jae Lee, Yun-Sil Lee.   

Abstract

Protein kinase C (PKC) isoforms play distinct roles in cellular functions. We have previously shown that ionizing radiation activates PKC isoforms (alpha, delta, epsilon, and zeta), however, isoform-specific sensitivities to radiation and its exact mechanisms in radiation mediated signal transduction are not fully understood. In this study, we showed that overexpression of PKC isoforms (alpha, delta, epsilon, and zeta) increased radiation-induced cell death in NIH3T3 cells and PKC epsilon overexpression was predominantly responsible. In addition, PKC epsilon overexpression increased ERK1/2 activation without altering other MAP-kinases such as p38 MAPK or JNK. Co-transfection of dominant negative PKC epsilon (PKC epsilon -KR) blocked both PKC epsilon -mediated ERK1/2 activation and radiation-induced cell death, while catalytically active PKC epsilon construction augmented these phenomena. When the PKC epsilon overexpressed cells were pretreated with PD98059, MEK inhibitor, radiation-induced cell death was inhibited. Co-transfection of the cells with a mutant of ERK1 or -2 (ERK1-KR or ERK2-KR) also blocked these phenomena, and co-transfection with dominant negative Ras or Raf cDNA revealed that PKC epsilon -mediated ERK1/2 activation was Ras-Raf-dependent. In conclusion, PKC epsilon -mediated ERK1/2 activation was responsible for the radiation-induced cell death.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12581866     DOI: 10.1016/s0167-4889(02)00392-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  MAP kinases: differential activation following in vivo and ex vivo irradiation.

Authors:  Anirban Kumar Mitra; Rakesh Kumar Singh; Malini Krishna
Journal:  Mol Cell Biochem       Date:  2006-11-29       Impact factor: 3.396

2.  Diazoxide acts more as a PKC-epsilon activator, and indirectly activates the mitochondrial K(ATP) channel conferring cardioprotection against hypoxic injury.

Authors:  M-Y Kim; M J Kim; I S Yoon; J H Ahn; S H Lee; E J Baik; C-H Moon; Y-S Jung
Journal:  Br J Pharmacol       Date:  2006-10-16       Impact factor: 8.739

3.  Mitogen-activated protein kinase phosphatase-1 inhibition and sustained extracellular signal-regulated kinase 1/2 activation in camptothecin-induced human colon cancer cell death.

Authors:  Minyoung Lee; Sun Young Kim; Jongguk Kim; Hak-Su Kim; Sang-Man Kim; Eun Ju Kim
Journal:  Cancer Biol Ther       Date:  2013-08-28       Impact factor: 4.742

4.  Protein kinase Cdelta supports survival of MDA-MB-231 breast cancer cells by suppressing the ERK1/2 pathway.

Authors:  Gry Kalstad Lønne; Katarzyna Chmielarska Masoumi; Johan Lennartsson; Christer Larsson
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

5.  Protein kinase C delta regulates airway mucin secretion via phosphorylation of MARCKS protein.

Authors:  Jin-Ah Park; Anne L Crews; William R Lampe; Shijing Fang; Joungjoa Park; Kenneth B Adler
Journal:  Am J Pathol       Date:  2007-11-30       Impact factor: 4.307

6.  Functional characterization of the ectopically expressed olfactory receptor 2AT4 in human myelogenous leukemia.

Authors:  S Manteniotis; S Wojcik; P Brauhoff; M Möllmann; L Petersen; J R Göthert; W Schmiegel; U Dührsen; G Gisselmann; H Hatt
Journal:  Cell Death Discov       Date:  2016-01-25

Review 7.  Dual effects of active ERK in cancer: A potential target for enhancing radiosensitivity.

Authors:  Yinliang Lu; Baocai Liu; Ying Liu; Xinyue Yu; Guanghui Cheng
Journal:  Oncol Lett       Date:  2020-05-28       Impact factor: 2.967

8.  Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancer.

Authors:  X Pu; L Wang; J Y Chang; M A T Hildebrandt; Y Ye; C Lu; H D Skinner; N Niu; G D Jenkins; R Komaki; J D Minna; J A Roth; R M Weinshilboum; X Wu
Journal:  Clin Pharmacol Ther       Date:  2014-07-23       Impact factor: 6.875

Review 9.  Radiation-induced signaling pathways that promote cancer cell survival (review).

Authors:  Ashley L Hein; Michel M Ouellette; Ying Yan
Journal:  Int J Oncol       Date:  2014-08-20       Impact factor: 5.650

10.  The molecular mechanism of anticancer action of novel octahydropyrazino[2,1-a:5,4-a']diisoquinoline derivatives in human gastric cancer cells.

Authors:  Natalia Pawłowska; Agnieszka Gornowicz; Anna Bielawska; Arkadiusz Surażyński; Anna Szymanowska; Robert Czarnomysy; Krzysztof Bielawski
Journal:  Invest New Drugs       Date:  2018-03-17       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.